By engineering an artificial protein that targets the product of such potentially cancer - causing gene fusions, Hur hopes to
trigger immune defense mechanisms that kill rogue cells harboring the fusions.
When a healthy person gets sick, the body has a natural
immune response which
triggers the first line of
defense (innate
immune response) that then call the second line of
defense (adaptive
immune response) into action and raise the antibody response.